IP Library Granted Patent US 7,960,437
Granted Patent B2
US 7,960,437 · App. 11/040,534 · Granted Jun 14, 2011

Skin care composition that mediates cell to cell communication

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,437
App. No.
11/040,534
Granted
Jun 14, 2011
Kind
B2
Abstract

There are disclosed skin treatment compositions containing cell signaling compounds, which induce and promote the biosynthesis and/or bioactivity of endogenous chemicals that mediate cell to cell communication in the skin between keratinocytes, fibroblasts and other cell types present in the skin. The cell signaling compound is selected from the group consisting of: andrographolide and its derivatives; adenosine cyclic phosphate and its derivatives; hydrolyzed milk proteins; sunflower seed extract; plankton extract; phytol and its derivatives; and mixtures thereof.

Claims (14)

1. A method of treating wrinkles and fine lines on the skin, comprising topically applying to an area of the skin in need thereof an effective amount of a composition comprising

a) a cosmetically acceptable carrier,

b) a first compound of phytol,

c) a second compound of a sunflower seed extract, and

d) a third compound of andrographolide.

2. The method of claim 1 , wherein the composition is an oil-in-water emulsion.

3. The method of claim 1 , wherein the first, second, and third compounds are present in the composition from about 0.1 wt % to about 2.5 wt % based on the total weight of the composition.

4. The method of claim 1 , wherein the composition further comprises a fourth compound of a plankton extract.

5. The method of claim 1 , wherein the composition further comprises a fourth compound of adenosine 3′,5′-monophosphate.

6. The method of claim 1 , wherein the composition further comprises a fourth compound of a hydrolyzed milk protein.

7. The method of claim 1 , wherein the composition is topically applied daily for at least one week.

8. The method of claim 1 , wherein phytol is present in an amount of from about 0.0001 to about 5%.

9. The method of claim 1 , wherein the sunflower seed extract is present in an amount of from about 0.01 to about 5%.

10. The method of claim 1 , wherein the andrographolide is present in an amount of from about 0.001 to about 1%.

Assignments (3)
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →